我們已在上線! 進一步了解
NVIV

InVivo Therapeutics Holdings Corp

已下市

NVIV已於2024年2月12日下市。

 

關於: InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.

員工: 6

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%
價格圖表採用Lightweight Charts™實作